Feasibility and Acceptability of Orthotic Shorts for People With Multiple Sclerosis

October 1, 2021 updated by: Sheffield Hallam University

A Clinical Trial Evaluating the Feasibility and Acceptability of Orthotic Shorts for Walking Function in People With Multiple Sclerosis.

Walking can be slow and unsteady in people with multiple sclerosis (MS). This study will investigate whether orthotic shorts might help.

Orthotic shorts are similar to the tight clothing believed to improve performance in athletes. Research suggests that such shorts help stroke survivors to walk faster. Some people with MS find that similar garments improve coordination and stability. Public funding is controversial because there is no research investigating whether they work in people with MS.

This is a cross-over study in which participants will each trial two different pairs of shorts. The first aim is to determine whether these shorts are acceptable to people with MS. Secondly, the study will develop the tools required to test the shorts. For example, by determining which measures seem most appropriate and if specific factors predict whether the shorts might help. The hypothesis being tested is that the shorts are acceptable.

People with MS will be invited to participate in this mixed methods study, aiming for a sample size of 16 people. Participants will trial two different pairs of shorts, one of which will fit more closely than the other. The shorts will be tested in a movement laboratory and in daily life.

In the movement laboratory, participants will be measured in both pairs of shorts and in normal, loose clothing. Walking pattern, speed and variability will be measured when the shorts are first worn.

Participants will test shorts in their normal daily life for up to two weeks. They will complete questionnaires about their walking and balance in the different shorts and record how long they wear the shorts. Interviews will explore expectations and experiences of the shorts and of the research study.

In the analyses, data from interviews will be combined with the numerical information gained from laboratory measures, diaries and questionnaires. If the shorts are acceptable, this study will inform a larger trial investigating effectiveness.

Study Overview

Detailed Description

Study design - This is a mixed methods, randomised cross-over study investigating two different pairs of orthotic shorts. The shorts will be tested in two main ways, firstly, the impact of the shorts on objectively assessed walking ability when first worn and, secondly, acceptability and impact of the shorts on self-perceived ability over a two-week period when the shorts are worn in the community.

Participants - Participants will be people with multiple sclerosis (PwMS) who identify themselves as having some difficulty walking, with a lack of stability around the hips and/or lower trunk. The study aims to recruit 16 PwMS over a 15-16-month period. It is felt that a sample size of 16 will enable the shorts to be trialled with participants with a range of different movement problems as well as different ages, genders and activity levels. These characteristics may impact upon the effect and acceptability of the shorts.

Recruitment - Participants will be made aware of the study through flyers, online advertisements and in discussion with local healthcare professionals. Potential participants will be identified through a local neurological therapy service.

Procedure - Each participant will visit Sheffield Hallam University on four occasions and be seen at home on three occasions.

The first Sheffield Hallam visit (Appointment 1) will include informed consent, collection of basic participant details, an initial interview around expectations and motivations, completion of self-report measures, assessment and measurement for shorts with a representative from the orthotics company and provision of a falls diary for completion over the following two weeks. Participants will be randomly assigned to the order in which the different shorts will be tested.

The second and third Sheffield Hallam visits (Appointments 3 and 5) follow the same structure with each visit testing one of the two pairs of shorts. Firstly, walking ability without the shorts will be measured. They will put the shorts on and spend about 30 minutes becoming familiar with wearing the shorts before the objective measures are repeated. After the objective assessments, participants will be provided with further information on wearing and caring for the shorts and a wear diary and falls diary to be completed whilst the shorts are trialed at home.

The final Sheffield Hallam visit (Appointment 7) will include a final measure of walking ability without shorts plus a semi-structured interview around the participants' experiences of the shorts and the trial.

In between the above visits to Sheffield Hallam, there will be three shorter visits. Each participant can choose to attend university or meet in an agreed location if preferred. The first of these (Appointment 2) will be with the representative from the orthotics company to check the fit of the shorts and measure the pressure exerted by the shorts. If adjustments are required at this point, this will be done within 3 days and the shorts will then be delivered to the chief investigator. Appointments 4 and 6 are to collect the shorts, the diaries and the self-report measures reporting the perceived impact of the shorts after the period of home wear.

Intervention - The orthotic shorts will be custom-made by a UK based company that specialises in dynamic, elastomeric orthoses for healthcare and sport. They will provide two pairs of shorts for each participant, which will differ in the closeness of their fit. The company representative, who will assess each participant, will decide the compression and fit of the shorts, such as whether support for the lower trunk is required. The shorts can be manufactured with a toileting hole, if preferred, allowing participants to toilet without removing the shorts. Shorts with a toileting hole are usually worn beneath usual underwear.

Randomisation and allocation - Counter-balancing will ensure that half the group use the more closely fitting shorts first and half the looser shorts first. A randomisation schedule will be created by a using the Sealed Envelope online system for blocked randomisation. Shorts will be placed into sealed envelopes labelled "Shorts 1" and "Shorts 2" by a third party using the randomisation schedule.

Data collection - Semi-structured interviews will be conducted on two occasions for each participant - at the first appointment and at the final appointment.

At Appointment 1, participants will be interviewed to explore their motivations for joining the study, their expectations of the shorts, their current daily activities and their readiness for change. The data from this interview will enable investigation of whether certain aims, motivations or perceptions impact upon the eventual acceptability of the shorts. This initial interview is likely to last 20 - 40 minutes.

At Appointment 7, participants will be interviewed about their experiences during the study. This interview aims to determine the acceptability of the shorts and participants' views on the study processes such as the information and support they received, and the outcome measures used. Prior to the interview, the interviewer will review the data and reflective notes from the initial interview; the wear diaries and the Participant Global Rating of Change scores at the initial assessment and will use this information to inform the questions that are asked. This will ensure the interviews are focussed on aspects that are important to each participant. This final interview is likely to last 40 - 60 minutes.

Measures of walking ability - Outcome measures are described elsewhere and have been chosen according to current guidelines on the most relevant assessment battery for walking in PwMS. In addition to movement laboratory measures, participants will complete self-report assessments of their walking and balance; a falls diary and a rating of the overall impact on the shorts on their walking ability.

Data analysis - Qualitative and quantitative data will first be analysed separately and then combined, partly by transforming qualitative into categorical data where this provides a valid representation of the data and partly by comparing, contrasting and relating the findings of the different data types for each objective.

Qualitative data analysis will use the Framework Approach to thematic analysis.

Descriptive quantitative data analysis will determine individual and average changes on each measure and effect sizes for the impact of the shorts. Effect sizes will indicate which measures are most responsive to this intervention and this information may be used to inform a sample size calculation for future studies.

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • South Yorkshire
      • Sheffield, South Yorkshire, United Kingdom, S10 2JF
        • Sheffield Teaching Hospitals NHS Foundation Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosed as having multiple sclerosis of any type (relapsing-remitting, primary progressive or secondary progressive).
  • Clinically stable - have not experienced relapse in the last 4 weeks; have not commenced a novel therapy in the last 3 months.
  • Able to travel to Sheffield Hallam University for assessments.
  • Have difficulty walking with a subjective feeling of instability around the hips or lower trunk.
  • Able to walk for at least 2 minutes at a time.
  • Able to provide a written record of informed consent.

Exclusion Criteria:

  • People who do not meet inclusion criteria.
  • Skin conditions that may be exacerbated by tight clothing.
  • Circulatory problems that may be exacerbated by tight clothing, such as varicose veins, previous thrombosis, venous or arterial insufficiency.
  • Cognitive problems including memory disturbance that may impact on recall of experience and adherence to guidance.
  • Pregnancy - because of related circulatory problems.
  • Living further than 10 miles from Sheffield if they are unable to provide own transport and the home visits would be too far for the researcher to travel.
  • Have previously used orthotic shorts.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Close-fitting orthotic shorts condition
Orthotic shorts will be made to measure for each participant, designed to provide some compression to the hips, pelvis and thighs and to provide support. Shorts will be worn during objective testing of walking ability and then taken home. Wear will be increased gradually over 5 days but then worn every day during normal daily activity.
The orthotic shorts will be custom-made by DM Orthotics, a UK based company that specialises in dynamic, elastomeric orthoses for healthcare and sport. They will provide both pairs of shorts for each participant, both constructed from a 275 g/m2 fabric, which is 51% Polyamide, 32% Dorlastan and 17% cotton. A company representative will assess each participant to decide the compression and fit of the shorts, such as whether support for the lower trunk is required. The shorts can be manufactured with a toileting hole, if preferred, allowing participants to toilet without removing the shorts. Shorts with a toileting hole are worn beneath usual underwear.
Other Names:
  • Lycra garment, Dynamic Elastomeric Fabric Orthosis
ACTIVE_COMPARATOR: Looser fitting shorts condition
Looser shorts will be made to measure for each participant, designed to look similar to the orthotic shorts but provide minimal support or compression. Shorts will be worn during objective testing of walking ability and then taken home. Wear will be increased gradually over 5 days but then worn every day during normal daily activity.
Looser fitting shorts will be custom-made by DM Orthotics, a UK based company that specialises in dynamic, elastomeric orthoses for healthcare and sport. Shorts will be constructed from a 275 g/m2 fabric, which is 51% Polyamide, 32% Dorlastan and 17% cotton. A company representative will assess each participant to decide the fit of the shorts. The shorts can be manufactured with a toileting hole, if preferred, allowing participants to toilet without removing the shorts. Shorts with a toileting hole are worn beneath usual underwear.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to wear protocol
Time Frame: After two weeks of shorts wear
Adherence will be calculated as hours worn as a percentage of hours of wear requested.
After two weeks of shorts wear

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cadence
Time Frame: At baseline and on Day 1 of shorts wear
A GAITRite system will be used to assess spatio-temporal gait parameters. Participants will walk 4 times over a 5.18m walkway.
At baseline and on Day 1 of shorts wear
Step length
Time Frame: At baseline and on Day 1 of shorts wear
A GAITRite system will be used to assess spatio-temporal gait parameters. Participants will walk 4 times over a 5.18m walkway.
At baseline and on Day 1 of shorts wear
Proportion of gait cycle in double support
Time Frame: At baseline and on Day 1 of shorts wear
A GAITRite system will be used to assess spatio-temporal gait parameters. Participants will walk 4 times over a 5.18m walkway.
At baseline and on Day 1 of shorts wear
Width of base of support
Time Frame: At baseline and on Day 1 of shorts wear
A GAITRite system will be used to assess spatio-temporal gait parameters. Participants will walk 4 times over a 5.18m walkway.
At baseline and on Day 1 of shorts wear
Variability of step length
Time Frame: At baseline and on Day 1 of shorts wear
A GAITRite system will be used to assess spatio-temporal gait parameters. Participants will walk 4 times over a 5.18m walkway.
At baseline and on Day 1 of shorts wear
Variability of stride time
Time Frame: At baseline and on Day 1 of shorts wear
A GAITRite system will be used to assess spatio-temporal gait parameters. Participants will walk 4 times over a 5.18m walkway.
At baseline and on Day 1 of shorts wear
Variability of stride width
Time Frame: At baseline and on Day 1 of shorts wear
A GAITRite system will be used to assess spatio-temporal gait parameters. Participants will walk 4 times over a 5.18m walkway.
At baseline and on Day 1 of shorts wear
Trunk stability in walking
Time Frame: At baseline and on Day 1 of shorts wear
Acceleration of the trunk and pelvis during gait will be assessed with inertial movement sensors.
At baseline and on Day 1 of shorts wear
Walking speed
Time Frame: At baseline and on Day 1 of shorts wear
Timed 25-foot walk (T25FW)
At baseline and on Day 1 of shorts wear
Cognitive demand of walking
Time Frame: At baseline and on Day 1 of shorts wear
Dual task cost will be calculated using the T25FW. Participants will be asked to walk as fast as possible whilst naming alternate letters of the alphabet. The percentage change in walking speed will be calculated, compared to the T25FW assessed without a cognitive task.
At baseline and on Day 1 of shorts wear
Participant rated perception of effect
Time Frame: On Day 1 of shorts wear
Assessed with a Global Rating of Change scale
On Day 1 of shorts wear
Self-perceived walking ability
Time Frame: At baseline and after two weeks of shorts wear
12-item Multiple Sclerosis Walking Scale
At baseline and after two weeks of shorts wear
Balance confidence
Time Frame: At baseline and after two weeks of shorts wear
Activities Specific Balance Confidence scale (ABC),
At baseline and after two weeks of shorts wear
Frequency of falls
Time Frame: At baseline and after two weeks of shorts wear
Falls diary
At baseline and after two weeks of shorts wear

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 10, 2018

Primary Completion (ACTUAL)

May 30, 2019

Study Completion (ACTUAL)

May 30, 2019

Study Registration Dates

First Submitted

April 11, 2017

First Submitted That Met QC Criteria

May 19, 2017

First Posted (ACTUAL)

May 23, 2017

Study Record Updates

Last Update Posted (ACTUAL)

October 4, 2021

Last Update Submitted That Met QC Criteria

October 1, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Following study completion, anonymised data on walking ability with and without orthotic shorts will be made available via the Sheffield Hallam University Research Data Archive.

IPD Sharing Time Frame

All anonymised data will be archived into the Sheffield Hallam University Research Data Archive in September 2019 at which point it will be openly available. This will not include interview recordings or transcripts because of the risk of participants being identied from this data.

IPD Sharing Access Criteria

Data will be available as Open Access.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multiple Sclerosis

Clinical Trials on Close-fitting orthotic shorts

3
Subscribe